A Systematic Review of Literature: TNF-α Blockers and JAK Inhibitors for the Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme.

Remicade (infliximab) - J&J

Altebrel (etanercept biosimilar) - AryoGen Pharmed

Humira (adalimumab) - AbbVie

tofacitinib - Generic mfg.

Enbrel (etanercept) - Pfizer, Amgen

http://www.ncbi.nlm.nih.gov/pubmed/42327458

Alireza Jafarzadeh; Azadeh Goodarzi; Mahsa Abbaspour; Nima Hajizadeh; Pooneh Torabi; Sadaf Salehi; Sara Sadeghi

Jun 23, 2026